Francesca Levi‐Schaffer

19.4k total citations · 2 hit papers
300 papers, 15.2k citations indexed

About

Francesca Levi‐Schaffer is a scholar working on Immunology, Physiology and Immunology and Allergy. According to data from OpenAlex, Francesca Levi‐Schaffer has authored 300 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Immunology, 128 papers in Physiology and 77 papers in Immunology and Allergy. Recurrent topics in Francesca Levi‐Schaffer's work include Mast cells and histamine (144 papers), Asthma and respiratory diseases (126 papers) and Immune Cell Function and Interaction (43 papers). Francesca Levi‐Schaffer is often cited by papers focused on Mast cells and histamine (144 papers), Asthma and respiratory diseases (126 papers) and Immune Cell Function and Interaction (43 papers). Francesca Levi‐Schaffer collaborates with scholars based in Israel, United States and Italy. Francesca Levi‐Schaffer's co-authors include Hans‐Uwe Simon, Abdulla Haj-Yehia, Adrian M. Piliponsky, Ariel Munitz, Ido Bachelet, Ilaria Puxeddu, Martin K. Church, Meir Shalit, Vladislav Temkin and С. Бонини and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Francesca Levi‐Schaffer

297 papers receiving 14.9k citations

Hit Papers

Role of reactive oxygen species (ROS) in apoptosis induction 2000 2026 2008 2017 2000 2017 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of reactive oxygen species (ROS) in apoptosis induction
    2000 2.4k citations Francesca Levi‐Schaffer et al. profile →
  2. The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
    2017 1.5k citations Francesca Levi‐Schaffer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Levi‐Schaffer Israel 62 6.2k 4.1k 3.8k 2.5k 1.9k 300 15.2k
Gianni Marone Italy 72 8.4k 1.4× 3.9k 1.0× 3.9k 1.0× 3.2k 1.3× 2.2k 1.2× 362 16.1k
K. Frank Austen United States 69 6.4k 1.0× 4.4k 1.1× 3.0k 0.8× 2.4k 1.0× 2.3k 1.2× 203 15.1k
Jean‐Michel Dayer Switzerland 74 7.2k 1.2× 1.6k 0.4× 4.9k 1.3× 1.8k 0.7× 4.5k 2.4× 223 20.4k
Morley D. Hollenberg Canada 78 3.3k 0.5× 2.8k 0.7× 6.9k 1.8× 1.5k 0.6× 653 0.3× 425 20.8k
Yoshiki Miyachi Japan 65 4.6k 0.7× 1.7k 0.4× 3.8k 1.0× 1.7k 0.7× 1.7k 0.9× 506 15.9k
Guo‐Ping Shi United States 72 5.4k 0.9× 2.1k 0.5× 6.6k 1.7× 1.6k 0.7× 1.4k 0.8× 266 18.1k
Michael P. Schön Germany 65 6.9k 1.1× 4.1k 1.0× 4.9k 1.3× 1.2k 0.5× 828 0.4× 462 19.7k
Thomas M. McIntyre United States 89 5.8k 0.9× 3.2k 0.8× 10.1k 2.6× 2.5k 1.0× 671 0.4× 240 26.2k
Marsha Wills‐Karp United States 63 7.2k 1.2× 8.4k 2.1× 2.3k 0.6× 3.3k 1.4× 439 0.2× 162 16.0k
Erwin W. Gelfand United States 86 11.8k 1.9× 9.2k 2.3× 6.8k 1.8× 3.7k 1.5× 1.1k 0.6× 610 27.3k

Countries citing papers authored by Francesca Levi‐Schaffer

Since Specialization
Citations

This map shows the geographic impact of Francesca Levi‐Schaffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Levi‐Schaffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Levi‐Schaffer more than expected).

Fields of papers citing papers by Francesca Levi‐Schaffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Levi‐Schaffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Levi‐Schaffer. The network helps show where Francesca Levi‐Schaffer may publish in the future.

Co-authorship network of co-authors of Francesca Levi‐Schaffer

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Levi‐Schaffer. A scholar is included among the top collaborators of Francesca Levi‐Schaffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Levi‐Schaffer. Francesca Levi‐Schaffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hadjileontiadis, Leontios J., Vasileios Charisis, Stelios Hadjidimitriou, et al.. (2025). European advances in digital rheumatology: explainable insights and personalized digital health tools for psoriatic arthritis. EClinicalMedicine. 84. 103243–103243. 1 indexed citations
2.
Sionov, Ronit Vogt, et al.. (2024). Antifungal properties of abnormal cannabinoid derivatives: Disruption of biofilm formation and gene expression in Candida species. Pharmacological Research. 209. 107441–107441. 1 indexed citations
3.
Puxeddu, Ilaria, et al.. (2024). Mast cell signaling and its role in urticaria. Annals of Allergy Asthma & Immunology. 133(4). 374–379. 8 indexed citations
4.
Pascal, Mariona, Heather J. Bax, Christoph Bergmann, et al.. (2024). Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper. Allergy. 79(9). 2319–2345. 2 indexed citations
5.
Gaur, Pratibha, Orly Marcu, Ora Schueler‐Furman, et al.. (2023). 2B4: A potential target in Staphylococcus aureus associated allergic inflammation. Clinical & Experimental Immunology. 215(1). 37–46. 2 indexed citations
6.
Roth‐Walter, Franziska, Ian M. Adcock, Cristina Benito‐Villalvilla, et al.. (2023). Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology. Allergy. 79(5). 1089–1122. 15 indexed citations
7.
8.
9.
Roth‐Walter, Franziska, Ian M. Adcock, Cristina Benito‐Villalvilla, et al.. (2018). Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper. Allergy. 74(3). 432–448. 31 indexed citations
10.
Galdiero, Maria Rosaria, et al.. (2017). Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer. Frontiers in Medicine. 4. 103–103. 85 indexed citations
11.
12.
Legrand, Fanny, Nadine Landolina, Francesca Levi‐Schaffer, & Amy D. Klion. (2016). Siglec-7 on Peripheral Blood Eosinophils: Surface Expression and Functional Analysis. Journal of Allergy and Clinical Immunology. 137(2). AB167–AB167. 1 indexed citations
13.
Kay, Gillian, Sagi Tshori, Hovav Nechushtan, et al.. (2014). Mitochondrial STAT3 plays a major role in IgE-antigen–mediated mast cell exocytosis. Journal of Allergy and Clinical Immunology. 134(2). 460–469.e10. 67 indexed citations
14.
Rocha-de-Souza, Cláudio Marcos, Beata Berent-Maoz, David Mankuta, Allon E. Moses, & Francesca Levi‐Schaffer. (2008). Human Mast Cell Activation by Staphylococcus aureus : Interleukin-8 and Tumor Necrosis Factor Alpha Release and the Role of Toll-Like Receptor 2 and CD48 Molecules. Infection and Immunity. 76(10). 4489–4497. 80 indexed citations
15.
Munitz, Ariel, Ido Bachelet, Fred D. Finkelman, Marc E. Rothenberg, & Francesca Levi‐Schaffer. (2007). CD48 Is Critically Involved in Allergic Eosinophilic Airway Inflammation. American Journal of Respiratory and Critical Care Medicine. 175(9). 911–918. 35 indexed citations
16.
Puxeddu, Ilaria, Rainer Bader, Adrian M. Piliponsky, et al.. (2005). The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts. Journal of Allergy and Clinical Immunology. 117(1). 103–110. 84 indexed citations
17.
Solomon, Abraham, Jacob Pe’er, & Francesca Levi‐Schaffer. (2001). Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies. Current Opinion in Allergy and Clinical Immunology. 1(5). 477–482. 22 indexed citations
18.
Levi‐Schaffer, Francesca, et al.. (1997). Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease. Bone Marrow Transplantation. 19(8). 823–828. 11 indexed citations
19.
Levi‐Schaffer, Francesca, Laurent Klapholz, Ari Kupietzky, et al.. (1991). Increased numbers of mast cells in pemphigus vulgaris skin lesions. A histochemical study.. Acta Dermato Venereologica. 71(3). 269–271. 18 indexed citations
20.
Levi‐Schaffer, Francesca & Ari Kupietzky. (1990). Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound. Experimental Cell Research. 188(1). 42–49. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianni Marone Breakdown of academic impact, for papers by K. Frank Austen Breakdown of academic impact, for papers by Jean‐Michel Dayer Breakdown of academic impact, for papers by Morley D. Hollenberg Breakdown of academic impact, for papers by Yoshiki Miyachi Breakdown of academic impact, for papers by Guo‐Ping Shi Breakdown of academic impact, for papers by Michael P. Schön Breakdown of academic impact, for papers by Thomas M. McIntyre Breakdown of academic impact, for papers by Marsha Wills‐Karp Breakdown of academic impact, for papers by Erwin W. Gelfand
Rankless by CCL
2026